Stock listing

Oslo:ABS Arctic Bioscience AS Aksje

Home listing (Oslo) of Arctic Bioscience AS

Follow Arctic Bioscience AS into a list and get an email when it puts out news.

Share price · OSL:ABS

2.53 NOK -0.16 (-5.9%)

Close on Nov 20, 2026

Past year -27.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
2.25 – 2.55 NOKNov 20, 2026
Volume
14,453 sharesNov 20, 2026
Market cap
68.20M NOKAt the close on Nov 20, 2026 · price × 26.96M shares outstanding
52-week range
2.05 – 3.90 NOKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
19,478 NOKMedian day 1,764 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Arctic Bioscience AS logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Oslo:ABS · Home2.53 NOK-0.16 (-5.9%)14,4532.552.552.252.69Close on Nov 20, 2026
Frankfurt:9TD€0.209 EUR-0.014 (-6.3%)—€0.209€0.209€0.209€0.223Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OSL:ABS · NOK, adjusted for splits

DayCloseChange%OpenHighLowVolume
2.53-0.16-5.9%2.552.552.2514,453
2.690.000.0%2.502.692.501,366
2.69-0.07-2.5%2.502.692.50940
2.76+0.22+8.7%2.762.762.76264
2.54+0.09+3.7%2.542.542.54100
2.45+0.16+7.0%2.612.612.405,374
2.29-0.21-8.4%2.202.492.1064,968
2.50-0.05-2.0%2.672.672.5012,730
2.55+0.16+6.7%2.202.552.20800
2.39-0.31-11.5%2.202.422.2017,885
2.700.000.0%2.702.702.7030
2.70+0.27+11.1%2.702.702.7030
2.43-0.06-2.4%2.202.432.20200
2.49+0.29+13.2%2.532.532.49170
2.200.000.0%2.102.282.101,801
2.20-0.20-8.3%2.302.412.1718,400
2.40-0.17-6.6%2.332.492.057,278
2.57-0.03-1.2%2.572.572.57100
2.60+0.24+10.2%2.602.602.601,000
2.36+0.07+3.1%2.362.362.361,010
2.29+0.19+9.0%2.202.362.201,847
2.10-0.30-12.5%2.102.102.101,200
2.40-0.10-4.0%2.402.402.401,900
2.50+0.19+8.2%2.202.502.208,100
2.31-0.28-10.8%2.502.542.3120,421
2.59+0.21+8.8%2.292.592.295,050
2.38-0.03-1.2%2.492.492.3810,100
2.410.000.0%2.602.602.41152
2.41-0.23-8.7%2.422.422.4112,000
2.64-0.01-0.4%2.372.642.36804
2.65-0.11-4.0%2.652.652.657
2.760.000.0%2.762.762.760
2.76-0.04-1.4%2.762.762.76200
2.800.000.0%2.802.802.800
2.800.000.0%2.802.802.80100
2.80+0.20+7.7%2.802.802.80100
2.600.000.0%2.652.652.473,687
2.60-0.13-4.8%2.522.602.52287
2.73-0.01-0.4%2.752.752.73590
2.74+0.09+3.4%2.742.742.74100
2.65-0.14-5.0%2.522.802.5220,553
2.790.000.0%2.792.792.791,764
2.790.000.0%2.522.792.521,764
2.79-0.01-0.4%2.502.792.501,509
2.800.000.0%2.802.802.804
2.80+0.01+0.4%2.802.802.804
2.79+0.09+3.3%2.802.802.556,908
2.70-0.09-3.2%2.502.702.501,700
2.79+0.04+1.5%2.802.802.791,680
2.75-0.03-1.1%2.502.772.503,942
2.780.000.0%2.782.782.781,372
2.78-0.01-0.4%2.602.782.601,372
2.790.000.0%2.792.792.794,904
2.79+0.04+1.5%2.662.792.654,904
2.750.000.0%2.752.752.757,082
2.75+0.16+6.2%2.782.782.337,082
2.59-0.19-6.8%2.782.792.5910,552
2.78-0.01-0.4%2.792.792.524,900
2.79+0.10+3.7%2.552.792.505,659
2.69-0.01-0.4%2.652.802.5280,765
2.70-0.10-3.6%2.802.802.5530,929
2.80-0.06-2.1%2.582.802.5829,349
2.86+0.06+2.1%2.852.872.841,752
2.80-0.07-2.4%2.892.892.8012,421
2.87-0.17-5.6%2.892.902.8036,329
3.04+0.04+1.3%2.933.182.932,902
Ticker
Oslo:ABS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Oslo
Currency
NOK

What changed lately

Latest news

All Arctic Bioscience AS news

Arctic Bioscience AS on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 19 in all · newest Aug 27, 2026 · oldest 2025
Decks
6 decks · latest Nov 11, 2026

Where Arctic Bioscience AS is listed

ListingExchangeCountryCurrency
Oslo:ABS · Home listing · This pageOsloNorwayNOK
Frankfurt:9TDFrankfurtGermanyEUR
Stuttgart:9TDStuttgartGermanyEUR

Valuation

EV/sales 2.8× against a median of 6.2×: 3rd lowest of 5 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
111.0M NOK
P/E
Loss
EV/sales
2.8×
EV/EBITDA
Negative EBITDA
Price/book
0.4×
Gross margin
27.5%
Operating margin
−83.4%
Net margin
−102.3%
Debt to equity
0.3×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Arctic Bioscience AS · OSL:ABSUS$7.00MUS$11.38Mn/a2.8×n/a0.4×−102.3%0.3×n/a
Ascelia Pharma AB · OMXSTO:ACEUS$7.30MUS$3.63Mn/an/an/a0.8×n/a0.0×n/a
AEON Biopharma, Inc. · AMEX:AEONUS$7.27M−US$4.15Mn/an/an/a3.0×n/a0.0×1.04
Pila Pharma AB · OMXSTO:PILAUS$7.01MUS$6.70Mn/an/an/a4.5×n/a0.0×n/a
Cadrenal Therapeutics, Inc. · NASDAQ:CVKDUS$7.01MUS$3.95Mn/an/an/a2.4×n/a0.0×1.60
Ensysce Biosciences, Inc. · NASDAQ:ENSCUS$7.00M−US$22.51Mn/a−3.6×n/a0.3×n/a0.0×1.28
Alaunos Therapeutics, Inc. · NASDAQ:TCRTUS$6.99MUS$6.37Mn/a2,124×n/a7.2×n/a0.0×0.90
Curanex Pharmaceuticals Inc · NASDAQ:CURXUS$6.92MUS$5.88Mn/an/an/a2.7×n/a0.2×0.84
Cambium Bio Ltd · ASX:CMBUS$6.82MUS$6.18Mn/a14.6×n/a4.3×−638.4%0.1×n/a
MetaVia Inc. · NASDAQ:MTVAUS$6.81M−US$1.97Mn/an/an/a2.8×n/a0.0×1.22
Aligos Therapeutics, Inc. · NASDAQ:ALGSUS$6.64M−US$12.55Mn/a−2.1×n/a0.6×n/a1.1×1.63
Median of the othersUS$7.00MUS$3.79M6.2×2.8×−638.4%0.0×1.22

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
15.00 NOK · Analysts' mean
EPS, year to Dec 2026
-0.89 · 1 analyst
Revenue, year to Dec 2026
58M · 1 analyst

Team and board

OfficerRole
Christer ValderhaugCEO
Jone R. SlinningCFO
Per Christian SæbøCOO
Steffen EidalSVP Sales and Marketing
Yuming FengEVP Global Business Development
Daniele MancinelliCTO
Hogne HallaråkerCSO/ Founder

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings32 slidesNov 11, 2026
H1 2026 Earnings PresentationEarnings29 slidesAug 27, 2026
Q1 2026 Earnings PresentationEarnings29 slidesApr 30, 2026
Q4 2025 Earnings PresentationEarnings27 slidesFeb 26, 2026
Q4 2023 Earnings PresentationEarnings30 slidesMar 1, 2024
Investor Presentation (March 2021)Investor deck24 slidesMarch 2021

Open Decks

Financials

Annual, in NOK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue40.1M43.5M33.8M34.3M21.5M20.5M30.0M24.8M
Cost of revenue29.1M31.6M24.0M22.6M16.4M15.2M17.8M15.9M
Gross profit11.0M11.9M9.78M11.6M5.16M5.31M12.2M8.95M
Research and development2.26M2.59M111.1K197.0K
Operating income-33.4M-47.8M-48.6M-37.4M40.6M-21.7M-3.08M-1.15M
Depreciation and amortization5.12M5.15M5.38M3.73M2.52M1.19M1.08M526.5K
EBITDA-28.3M-42.6M-43.2M-33.7M43.1M-20.5M-2.00M-623.2K
Interest expense9.09M3.15M992.6K4.22K2.12M2.12M582.9K575.4K
Income before tax-41.0M-47.9M-45.5M-34.0M-42.6M-22.6M-3.99M-1.71M
Income tax3.37M-82.8M561.2K-437.3K-40.6K
Net income-41.0M-47.9M-45.5M-34.0M-42.6M-22.6M-3.99M-1.71M
Earnings per share, basic-1.52-1.88-1.79-1.40-1.75-0.93-0.16-0.07

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents258.4K2.16M79.6M144.2M227.4M12.6M23.4M368.8K
Receivables10.2M25.6M20.8M18.7M11.0M13.8M12.3M6.00M
Inventory29.6M29.0M32.8M35.5M28.5M26.2M17.5M15.9M
Current assets49.3M57.9M133.2M198.3M266.9M52.6M54.1M24.0M
Property, plant and equipment22.3M16.0M6.36M3.14M
Goodwill1.34M1.93M2.53M
Total assets284.7M279.7M300.3M327.7M341.5M93.2M82.5M45.4M
Accounts payable26.0M19.0M18.4M18.3M8.36M9.93M6.47M5.86M
Current liabilities83.0M67.5M39.6M40.4M20.9M22.7M11.4M15.3M
Long-term debt27.4M02.05M006.58M7.16M8.24M
Total debt32.9M2.05M1.10M4.18K8.46M7.16M12.1M
Total liabilities111.2M69.0M41.7M40.4M20.9M29.3M18.6M23.5M
Shareholders' equity173.5M210.7M258.6M287.3M320.6M63.9M63.9M21.9M
Shares outstanding27.0M25.4M25.4M24.4M24.3M24.3M24.3M24.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-22.7M-45.4M-40.3M-25.4M-39.5M-21.9M2.16M
Capital spending-22.7M-50.8M-45.3M-58.6M-36.5M-13.4M-13.4M0
Free cash flow-45.4M-96.2M-85.6M-84.0M-76.0M-35.3M2.16M
Cash from investing-50.6M-43.1M-58.6M-36.5M-13.4M-13.4M
Cash from financing19.7M18.8M750.0K290.8M23.9M23.9M
Change in cash-1.99M-76.3M-64.5M-83.2M214.8M-11.4M23.2M

Open Financials

Cap table

Built by 6ix from Arctic Bioscience AS’ releases

Common shares
26,956,256
Fully diluted
26,956,256

Fully diluted

LineShares
Common shares26,956,256

Share count over time

CountShares
Nov 22, 202626,956,256

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christer L. ValderhaugCEO · Since at least Aug 27, 2026
Daniele MancinelliCTO · Since at least May 7, 2026
Hogne HallaråkerCSO/ Founder · Since at least May 7, 2026
Jan Endre VartdalMay 7, 2026 – Aug 27, 2026 · Past
Jone R. SlinningCFO · Since at least Aug 27, 2026
Per Christian SæbøCOO · Since at least May 7, 2026
Steffen EidalSVP Sales and Marketing · Since at least Nov 5, 2026
Yuming FengEVP Global Business Development · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Arctic Bioscience AS.